U.S. Markets close in 2 hrs 53 mins

Faruqi & Faruqi, LLP is Investigating Quest Diagnostics Incorporated (DGX) on Behalf of its Shareholders

NEW YORK, June 6, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at Quest Diagnostics Incorporated ("Quest Diagnostics" or the "Company") (DGX).

Faruqi & Faruqi, LLP. (PRNewsfoto/Faruqi & Faruqi, LLP)

The investigation focuses on whether the Company's Board of Directors and/or its officers breached their fiduciary duties. 

Request more information now by clicking here:  www.faruqilaw.com/DGX.  There is no cost or obligation to you.

Take Action

If you currently own Quest Diagnostics stock and have continuously owned Quest Diagnostics stock and would like to discuss your legal rights, please visit www.faruqilaw.com/DGX.  You can also contact us by calling Alex B. Heller toll free at (877) 247-4292 or by sending an e-mail to aheller@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Quest Diagnostics' conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
685 3rd Avenue, 26th Floor
New York, NY 10017
Attn: Alex B. Heller
aheller@faruqilaw.com
Telephone: (215) 277-5770

Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/faruqi--faruqi-llp-is-investigating-quest-diagnostics-incorporated-dgx-on-behalf-of-its-shareholders-300863544.html